Marion Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Hold
1,025
0.08% 116
2026
Q1
$361K Hold
1,025
0.08% 107
2025
Q4
$353K Hold
1,025
0.08% 106
2025
Q3
$289K Hold
1,025
0.07% 110
2025
Q2
$286K Hold
1,025
0.07% 112
2025
Q1
$319K Hold
1,025
0.09% 103
2024
Q4
$267K Hold
1,025
0.07% 115
2024
Q3
$330K Hold
1,025
0.09% 107
2024
Q2
$320K Hold
1,025
0.09% 103
2024
Q1
$291K Hold
1,025
0.09% 107
2023
Q4
$295K Hold
1,025
0.09% 104
2023
Q3
$275K Hold
1,025
0.1% 100
2023
Q2
$228K Hold
1,025
0.08% 101
2023
Q1
$248K Hold
1,025
0.09% 97
2022
Q4
$269K Hold
1,025
0.11% 91
2022
Q3
$231K Hold
1,025
0.12% 93
2022
Q2
$249K Buy
+1,025
New +$251K 0.13% 93

Other funds holding AMGN

Marion Wealth Management's AMGN Position: Q2 2026 in Review

Marion Wealth Management held its Amgen (AMGN) position steady in Q2 2026 at 1,025 shares worth $371K. The position accounts for 0.08% of the portfolio, ranked #116.

Marion Wealth Management first reported a position in AMGN in Q2 2022 and has held it in 17 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Marion Wealth Management held 1,025 shares of Amgen worth $371K as of Q2 2026.
  • Marion Wealth Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.08% of Marion Wealth Management's portfolio in Q2 2026, its #116 holding.
  • Marion Wealth Management first reported a position in Amgen in Q2 2022 and has held it in 17 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Marion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.